VIDEO: Community Leaders Breakfast
Dr. Stephen G. Emerson Appointed Director of the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center
Published: February 10, 2012
NEW YORK (Feb. 10, 2012) — A leading hematologist/oncologist and former president of Haverford College, Stephen G. Emerson, M.D., Ph.D., has been named director of the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center, effective April 1. The Cancer Center is one of only three National Institutes of Health–designated Comprehensive Cancer Centers ...
CBS THIS MORNING: New Findings on Behavior of Alzheimer’s
Published: February 6, 2012
Two new studies find that Alzheimer's disease seems to spread from cell to cell like an infection. Dr. Karen Duff speaks with Charlie Rose and Gayle King about these new findings.
Study Shows Alzheimer’s Disease May Spread by ‘Jumping’ from One Brain Region to Another
Published: February 1, 2012
Findings open new opportunities for studying Alzheimer’s and testing potential therapies New York, NY (February 1, 2012) — For decades, researchers have debated whether Alzheimer’s disease starts independently in vulnerable brain regions at different times, or if it begins in one region and then spreads to neuroanatomically connected areas. A new study by Columbia University Medical ...
Risks of Pregnancy via Egg Donation Similar for Women Over Age 50 as for Younger Women
Published: January 31, 2012
(NEW YORK, NY, January 31, 2012) – Although women over age 50 who become pregnant via egg donation are at an elevated risk for developing obstetrical complications, their complication rates are similar to those of younger recipients, according to a study by Columbia University Medical Center researchers to be published in the February 2012 issue ...
Study Pinpoints Genetic Variation that Raises Risk of Serious Complication Linked to Osteoporosis Drugs
Published: January 27, 2012
Findings could lead to screening test for determining who can safely take these medicines New York, NY (January 26, 2012) — Researchers at the Columbia University College of Dental Medicine have identified a genetic variation that raises the risk of developing serious necrotic jaw bone lesions in patients who take bisphosphonates, a common class of osteoclastic ...